Multiple System Atrophy: Advances in Diagnosis and Therapy

Area of Science:

• Neuroscience
• Neurology
• Pathophysiology

Background:

• Multiple system atrophy (MSA) is a complex neurodegenerative disorder.
• Understanding its pathophysiology and early clinical manifestations is crucial for effective management.
• Previous diagnostic criteria (2008) have been updated to facilitate therapeutic development.

Purpose of the Study:

• To review recent advancements in understanding MSA pathophysiology.
• To summarize improvements in early clinical symptom identification.
• To highlight progress in diagnostic methods and disease-modifying therapies for MSA.

Main Methods:

• Review of current literature on MSA pathophysiology, diagnostics, and therapeutics.
• Analysis of updated diagnostic criteria proposed in 2022.
• Examination of novel approaches in neuroimaging and treatment strategies.

Main Results:

• New insights into the roles of α-synuclein, neuroinflammation, and oligodendroglia in MSA pathogenesis.
• Enhanced diagnostic accuracy using artificial intelligence, machine learning, and deep learning in neuroimaging.
• Emerging therapies include immunotherapy, serotonin-targeted treatments, and mesenchymal stem cell therapy.

Conclusions:

• Accelerated progress in clarifying MSA pathogenesis.
• Improved diagnostic techniques aid in early detection.
• These developments are expected to accelerate the creation of disease-modifying therapies for MSA.